Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma

NCT03807947 is registered in ClinicalTrials.gov with Humanitas Clinical and Research Center as lead sponsor.

NCT NCT03807947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03807947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma
Lead sponsor
Humanitas Clinical and Research Center
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2019
Completion date
April 30, 2020
Enrollment
74 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, hepatocellular carcinoma non-resectable